Gunung Raja Paksi Tbk. vs Ikapharmindo Putramas Tbk. — how do they compare? Gunung Raja Paksi Tbk. trades at Rp302 (market cap 3.68T, 218.2K 24h volume), while Ikapharmindo Putramas Tbk. trades at Rp199 (market cap 330.19B, 215.9K 24h volume). The key difference: Gunung Raja Paksi Tbk. is far larger — about 11.1× Ikapharmindo Putramas Tbk.'s market cap, and Gunung Raja Paksi Tbk. is more actively traded (218.2K versus 215.9K). Which is the better fit depends on your goals.
| GGRP | IKPM | |
|---|---|---|
Market Cap | 3.68T | 330.19B |
Volume | 218.2K | 215.9K |
Lot | 2.18K | 2.16K |
Turnover | 65.68M | 42.44M |
Average Price | 301 | 196.56 |
Value | 65.68M | 42.44M |
Indicative Equilibrium Price | 304 | 199 |
Indicative Equilibrium Volume | 2K | 9 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Gunung Raja Paksi Tbk (the Company) was established under the name of PT Gunung Naga Mas based on Notarial Deed No.229 of Chairani Bustami,S.H. dated August 20,1990 that was amended by Notarial Deed No.25 dated June 6,1991. The change from Foreign Capital Investment (“FCI”) to Domestic Capital Investment (“DCI”) has been approved by the Capital Investment Coordinating Board of the Republic of Indonesia in its Letter No.346/1/IP/PMDN/2016 dated December 15, 2016.
Read more on GGRP →PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.
Read more on IKPM →